.png)
We are excited to share that Dr. Tomasz Grzywa recently presented his research at the 25th Annual Meeting of the Translational Research Cancer Centers Consortium (TRCCC)—Expediting Progress in Cancer Immunotherapy. This meeting brought together leading experts in cancer immunotherapy to discuss groundbreaking advancements in the field.
Tomasz’s presentation, titled "Directed Evolution-Based Discovery of Ligands for In Vivo Restimulation of CAR-T Cells," highlighted an innovative approach to enhancing CAR-T cell efficacy through in vivo restimulation. By leveraging directed evolution techniques, this work aims to identify novel ligands that improve CAR-T persistence and functionality, addressing key challenges such as limited expansion and persistence.
Comments